Rezultati pretraživanja
  1. prije 6 sati
    Odgovor korisniku/ci

    Thank you to and generous donation to for funding the amazing transformation to Montgomery Unit waiting room and reception. Thank you also for making it happen

  2. It’s a wrap! Day 3 of ⁦ and complete. Came away with a lot more knowledge, research collaborations, and motivation! Thank you ⁦⁩ !!!!

  3. This combination led to a promising objective response rate in patients with advanced sarcoma who typically have limited treatment options.

  4. Systemic therapy landscape for patients with tumor ⁦

  5. This is brilliant! Exercise is important in every part of the Cancer journey 👌👏.. so important to get an project in up and running 🏃 👆👆👆

  6. Kit Exon 9 mutant patients benefit from higher doses of imatinib up to 800 mg daily. Sadly, only 30% of patients are tested in the US.

  7. 20% of metastatic patients are alive for more than 10 years. ⁦

  8. High risk patients have 20% decrease in recurrence and 10% decrease in death at 5 years if treated with imatinib for 3 years. ⁦

  9. 4. velj
  10. 4. velj

    After three days full of interesting talks about pathology, surgery, genetics, radiation therapy and medical oncology sure there are interesting teaching points & state of the art notes Looking forward for them. I was not able to attend as others. Thanks

  11. 4. velj

    today I feel blessed to still have my mam here after she beat but I also offer prayers to those still suffering and going thru the fight with this horrid disease and thoughts to those who won't make it

  12. 4. velj

    ⁩ : ~50% of are , , or UPS. The other subtypes are double rare ⁦

  13. 4. velj

    Never, ever ignore a lump anywhere on your body. Solid tumors don’t just present in genitals. If a bump is -firm -immovable -uncomfortable -approaching 5 cm/2 in. Get it checked out. Don’t wait until it affects limb movement or becomes painful.

  14. 4. velj

    Sarcoma surgical margins matter even if one size doesn’t fit all. Enlightening presentation by Alessandro Gronchi.

  15. 4. velj
    Odgovor korisniku/ci

    One area of confusion is histopathologic grading. is not graded by experienced pathologists: ALL are high grade tumors. There is no such entity as a low grade or benign . Thus, the risks and benefits of chemotherapy should be discussed.

  16. 4. velj

    Global Consensus on now available with open access. Great achievement from collaboration effort.

  17. 3. velj

    Milan 3-5 February 2020 The main topic of the ESMO Conference: sarcoma CHALLENGES . Challenges in classification , in pathologic diagnosis, in surgery, in radiation therapies and in medical treatments ,

  18. 1. velj

    So proud if the Van Tine lab members for their hard work in tumor metabolism

  19. 31. sij

    Had the opportunity to share our approach to patient care and discuss research ideas with the outstanding team

  20. 31. sij

    I’m just home from after a 2nd week of intensive rehab following proximal femoral replacement for . I would like to commend the team in particular for their excellent care and support. This hospital is world class, thank you ❤️

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.